Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06797193 · ClinicalTrials.gov registry record · NA

Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension

A NA study of Portal Hypertension, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
3
Study locations

NCT06797193 is a NA study of Portal Hypertension that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 202-participant average among 9 other Portal Hypertension trials with a reported enrollment target (70% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06797193, a NA study of Portal Hypertension, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
3
Study locations

Study Summary

This clinical trial tests the how well an ultrasound with subharmonic imaging and the subharmonic aided pressure estimation (SHAPE) technique works in identifying portal hypertension (PH). An ultrasound takes pictures of the inside of the body by bouncing sound waves off organs. PH is high blood pressure in the vein that carries blood to the liver from the stomach, small and large intestines, spleen, pancreas, and gallbladder. The complications associated with PH are clear only after severe liver dysfunction or liver cirrhosis develops and are accompanied by relatively high mortality rates (20-70% mortality within 2 years). Thus, identifying PH earlier is beneficial. The hepatic venous pressure gradient (HVPG) obtained using an invasive catheterization procedure remains the standard for assessing PH. However, using this invasive procedure to assess PH prevents frequent pressure monitoring. Thus, a noninvasive technique to estimate PH is beneficial not only for diagnosis but also for monitoring treatment and disease progression. The SHAPE technique is a noninvasive ultrasound-based imaging technique that can estimate pressure with an ultrasound contrast agent. A noninvasive technique using an ultrasound with subharmonic imaging and the SHAPE technique may work in identifying PH.

Conditions Studied

Interventions

  • OTHER Medical Device Usage and Evaluation
  • OTHER Electronic Health Record Review
  • PROCEDURE Liver Biopsy
  • DRUG Perflutren Lipid Microspheres
  • PROCEDURE Ultrasound Imaging

Study Locations (3)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Florida

  • Mayo Clinic in Florida - Jacksonville

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-03-13
Est. Completion 2027-03-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06797193

The ClinicalTrials.gov registry entry for NCT06797193 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 202-participant average among 9 other Portal Hypertension trials with a reported enrollment target (70% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Portal Hypertension appearing as the primary indexed condition, and to 5 interventions - of which Medical Device Usage and Evaluation is the first listed.

NCT06797193 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT06797193 about?

NCT06797193 is a clinical study titled "Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension". This clinical trial tests the how well an ultrasound with subharmonic imaging and the subharmonic aided pressure estimation (SHAPE) technique works in identifying portal hypertension (PH). An ultrasound takes pictures of the inside of the body by bouncing sound waves off organs. PH is high blood pre...

What is the current status of trial NCT06797193?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-13. Estimated completion is 2027-03-31.

What conditions does trial NCT06797193 study?

This clinical trial studies the following conditions: Portal Hypertension.

What interventions are being tested in trial NCT06797193?

The interventions under investigation include: Medical Device Usage and Evaluation (OTHER), Electronic Health Record Review (OTHER), Liver Biopsy (PROCEDURE), Perflutren Lipid Microspheres (DRUG), Ultrasound Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT06797193?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06797193 being conducted?

This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Portal Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.